A Study of MORAb-009 in Patients With Solid Tumor
NCT01018784
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer
Mesothelin-positive
Interventions
DRUG:
MORAb-009
Sponsor
Eisai Co., Ltd.